Published in Neurotoxicol Teratol on January 24, 1997
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect (2000) 7.58
Does methylmercury have a role in causing developmental disabilities in children? Environ Health Perspect (2000) 1.35
Prenatal methylmercury exposure and children: neurologic, developmental, and behavioral research. Environ Health Perspect (1998) 1.25
Principles and practices of neurodevelopmental assessment in children: lessons learned from the Centers for Children's Environmental Health and Disease Prevention Research. Environ Health Perspect (2005) 1.17
Polychlorinated biphenyls, organochlorine pesticides and neurodevelopment. Curr Opin Pediatr (2008) 1.15
Selenium health benefit values as seafood safety criteria. Ecohealth (2009) 1.06
Selenium as a potential protective factor against mercury developmental neurotoxicity. Environ Res (2007) 0.98
Neurobehavioral deficits at age 7 years associated with prenatal exposure to toxicants from maternal seafood diet. Neurotoxicol Teratol (2012) 0.94
Neurobehavioral testing in human risk assessment. Neurotoxicology (2008) 0.93
Neurotoxicity from prenatal and postnatal exposure to methylmercury. Neurotoxicol Teratol (2014) 0.88
Negative confounding by essential fatty acids in methylmercury neurotoxicity associations. Neurotoxicol Teratol (2014) 0.85
Sensitivity of continuous performance test (CPT) at age 14 years to developmental methylmercury exposure. Neurotoxicol Teratol (2010) 0.84
Adaptation of the Behavioral Assessment and Research System (BARS) for evaluating neurobehavioral performance in Filipino children. Neurotoxicology (2007) 0.83
Cognitive deficits at age 22 years associated with prenatal exposure to methylmercury. Cortex (2015) 0.83
Association between exposure to electromagnetic fields from high voltage transmission lines and neurobehavioral function in children. PLoS One (2013) 0.83
Estimating uncertainty in observational studies of associations between continuous variables: example of methylmercury and neuropsychological testing in children. Epidemiol Perspect Innov (2007) 0.78
Childhood fears, neurobehavioral functioning and behavior problems in school-age children. Child Psychiatry Hum Dev (2009) 0.76
Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol (1997) 8.51
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Organochlorine exposure and risk of breast cancer. Lancet (1998) 3.18
Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health (1992) 3.16
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke (1998) 3.03
Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr (2000) 3.03
Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem (1997) 3.02
Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol (2001) 2.85
Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol (1999) 2.41
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Rationale, methodology, and pilot study results. J Occup Med (1985) 2.35
Differential inhibition of ketogenesis by malonyl-CoA in mitochondria from fed and starved rats. Biochem J (1980) 2.30
Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants. Int J Epidemiol (2001) 2.17
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology (1999) 1.86
Methylmercury neurotoxicity in Amazonian children downstream from gold mining. Environ Health Perspect (1999) 1.85
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health (1996) 1.65
Psychological dysfunctions in lead-exposed workers. Relation to biological parameters of exposure. Scand J Work Environ Health (1978) 1.61
Possible estuary-associated syndrome: symptoms, vision, and treatment. Environ Health Perspect (2001) 1.61
Relation of a seafood diet to mercury, selenium, arsenic, and polychlorinated biphenyl and other organochlorine concentrations in human milk. Environ Res (1995) 1.56
Fecundability in relation to body mass and menstrual cycle patterns. Epidemiology (1999) 1.56
Occupational lead neurotoxicity: improvement in behavioural effects after reduction of exposure. Br J Ind Med (1985) 1.55
Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res (1998) 1.54
Neurobehavioral effects of the on-call experience in housestaff physicians. J Occup Med (1991) 1.54
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
The sensitivity and specificity of tests for carpal tunnel syndrome vary with the comparison subjects. J Hand Surg Br (1998) 1.52
Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health (1993) 1.46
Upper-extremity musculoskeletal disorders of occupational origin. Annu Rev Public Health (1991) 1.45
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res (1991) 1.45
Breast cancer and dieldrin. Lancet (2000) 1.40
Influence of smoking and alcohol consumption on blood lead levels. Int Arch Occup Environ Health (1981) 1.40
Antioxidative enzyme activities in human erythrocytes. Clin Chem (1997) 1.36
Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress. Int J Epidemiol (1998) 1.36
Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull (1993) 1.33
Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke (1993) 1.30
Betaine-homocysteine transmethylase in Pseudomonas denitrificans, a vitamin B 12 overproducer. J Bacteriol (1973) 1.29
Learning disabilities in children: significance of low-level lead-exposure and confounding factors. Acta Paediatr Scand (1990) 1.29
Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol (1992) 1.27
Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol (1995) 1.26
Vibrotactile threshold measurement for detecting neurotoxicity: reliability and determination of age- and height-standardized normative values. Arch Environ Health (1990) 1.23
Activation of mitochondrial fatty acid oxidation by calcium. Conversion to the energized state. J Biol Chem (1978) 1.19
Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry (1985) 1.18
Catabolism of betaine and its relationship to cobalamin overproduction. Biochim Biophys Acta (1971) 1.17
Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology (1995) 1.17
Influenza vaccination in community elderly. A controlled trial of postcard reminders. J Am Geriatr Soc (1987) 1.17
Effects of age and body lead burden on CNS function in young children. II. EEG spectra. Electroencephalogr Clin Neurophysiol (1981) 1.17
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res (2000) 1.16
Isolation of Lyme disease Borrelia from puffins (Fratercula arctica) and seabird ticks (Ixodes uriae) on the Faeroe Islands. J Clin Microbiol (1999) 1.15
Human exposure to nickel. IARC Sci Publ (1984) 1.15
Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev (1992) 1.13
Lead concentration in deciduous teeth: variation related to tooth type and analytical technique. J Toxicol Environ Health (1986) 1.13
Evoked potentials in Faroese children prenatally exposed to methylmercury. Neurotoxicol Teratol (1999) 1.13
Benchmark dose calculations of methylmercury-associated neurobehavioural deficits. Toxicol Lett (2000) 1.12
Methylmercury: significance of intrauterine and postnatal exposures. Clin Chem (1994) 1.11
Benchmark dose calculation from epidemiological data. Biometrics (2001) 1.11
Specificity of the stimulatory effect of betaine on the vitamin B12 fermentation. Nature (1968) 1.10
Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control (2000) 1.09
Neurobehavioral effects of intrauterine mercury exposure: potential sources of bias. Environ Res (1993) 1.09
Relationship of psychiatric status to Gulf War veterans' health problems. Psychosom Med (1999) 1.08
Reliability of a widely used test of peripheral cutaneous vibration sensitivity and a comparison of two testing protocols. Br J Ind Med (1988) 1.08
Methylmercury dose estimation from umbilical cord concentrations in patients with Minamata disease. Environ Res (1998) 1.08
Human milk as a source of methylmercury exposure in infants. Environ Health Perspect (1994) 1.08
Health implications for Faroe islanders of heavy metals and PCBs from pilot whales. Sci Total Environ (1996) 1.07
Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med (1998) 1.06
Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull (1994) 1.06
Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol (1997) 1.06
Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci Biobehav Rev (1997) 1.06
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res (2001) 1.06
Changes with time in the distribution of virus and PR protein around single local lesions of TMV infected tobacco. Plant Mol Biol (1986) 1.05
Human neurobehavioral research methods: impact of subject variables. Environ Res (1997) 1.04
Neurobehavioral test performance in the third National Health and Nutrition Examination Survey. Neurotoxicol Teratol (2002) 1.04
Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol (1999) 1.04
Early detection of Alzheimer disease: methods, markers, and misgivings. Alzheimer Dis Assoc Disord (1997) 1.04
Selection bias in determining the age dependence of waiting time to pregnancy. Am J Epidemiol (2000) 1.03
The binding of palmitoyl-CoA to bovine serum albumin. Biochim Biophys Acta (1990) 1.02
Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab (1994) 1.02
Risk of cancer and exposure to gasoline vapors. Am J Epidemiol (1997) 1.02
Neurotoxic effects of heavy lead exposure determined with psychological tests. Toxicol Lett (1980) 1.01
The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol Teratol (1990) 1.01
Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology (2000) 1.01
Exposure of humans to a volatile organic mixture. II. Sensory. Arch Environ Health (1992) 1.01
Effect of overtime work on cognitive function in automotive workers. Scand J Work Environ Health (1996) 1.01